title: Prescription drug product labeling; medication guide requirements--FDA. Final rule.
abstract: The Food and Drug Administration (FDA) is establishing requirements for the distribution of patient labeling for selected prescription human drug and biological products used primarily on an outpatient basis. The agency is requiring the distribution of patient labeling, called Medication Guides, for certain products that pose a serious and significant public health concern requiring distribution of FDA-approved patient medication information. The intent of this action is to improve public health by providing information necessary for patients to use their medications safely and effectively. FDA believes that this program will result in direct improvements in the safe and effective use of prescription medications.
mesh_terms: D003256:Community Participation; D004348:Drug Labeling / Q000331:legislation & jurisprudence* / Q000592:standards; D011307:Drug Prescriptions / Q000592:standards*; D006801:Humans; D010353:Patient Education as Topic; D011634:Public Health; D014481:United States; D014486:United States Food and Drug Administration